Neuronetics (NASDAQ: STIM)
Neuronetics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Neuronetics Company Info
Neuronetics, Inc. commercial stage medical technology company, which engages in the designing, developing and marketing products for the patients suffering from psychiatric disorders. It operates through United States and International geographical segments. The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
News & Analysis
Valuation
Earnings Transcripts
Neuronetics, Inc. (STIM) Q2 2022 Earnings Call Transcript
STIM earnings call for the period ending June 30, 2022.
Neuronetics, Inc. (STIM) Q1 2022 Earnings Call Transcript
STIM earnings call for the period ending March 31, 2022.
Neuronetics, Inc. (STIM) Q4 2021 Earnings Call Transcript
STIM earnings call for the period ending December 31, 2021.
Neuronetics, Inc. (STIM) Q3 2021 Earnings Call Transcript
STIM earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.